Neoadjuvant chemotherapy for resectable colorectal liver metastases: What is the evidence? Results of a systematic review of comparative studies

Surgeon

Volumn 13, Issue 2, 2015, Pages 83-90

  Nigri, Giuseppe ^a   Petrucciani, Niccolò ^a   Ferla, Fabio ^b   La Torre, Marco ^a   Aurello, Paolo ^a   Ramacciato, Giovanni ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Colorectal metastases; Hepatectomy; Liver metastases; Neoadjuvant chemotherapy; Preoperative chemotherapy; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT;

COLORECTAL NEOPLASMS; HUMAN; LIVER NEOPLASMS; LIVER RESECTION; NEOADJUVANT THERAPY; PATHOLOGY; SECONDARY;

ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; NEOADJUVANT THERAPY;

EID: 84926095802     PISSN: 1479666X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surge.2014.07.005     Document Type: Review

References (31)

1. Jemal A., Bray F., Center M.M., et al. Global cancer statistics. CA Cancer J Clin 2011, 61:69.
2. Adam R., De Gramont A., Figueras J., et al. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. Oncologist 2012, 17:1225-1239.
3. Siegel R., Naishadham D., Jemal A. Cancerstatistics, 2013. CA Cancer J Clin 2013, 63:11.
4. Zdenkowski N., Chen S., van derWesthuizen A., Ackland S. Curative strategies for liver metastases from colorectal cancer: a review. Oncologist 2012, 17:201-211.
5. Lehmann K., Rickenbacher A., Weber A., Pestalozzi B.C., Clavien P.A. Chemotherapy before liver resection of colorectal metastases: friend or foe?. Ann Surg 2012, 255:237-247.
6. Wicherts D.A., de Haas R.J., Salloum C., et al. Repeathepatectomy for recurrentcolorectal metastases. Br J Surg 2013, 100:808-818.
7. Mahnken A.H., Pereira P.L., de Baère T. Interventional oncologic approaches to liver metastases. Radiology 2013, 266:407-430.
8. Jones R.P., Malik H.Z., Fenwick S.W., Poston G.J. Perioperativechemotherapy for resectablecolorectallivermetastases: wherenow?. Eur J Surg Oncol 2013, 39:807-811.
9. Zhu D., Zhong Y., Wei Y., et al. Effect of neoadjuvant chemotherapy in patients with resectable colorectal liver metastases. PLoS One 2014, 9. e86543.
10. Araujo R., Gonen M., Allen P., et al. Comparison between perioperative and postoperative chemotherapy after potentially curative hepatic resection for metastatic colorectal cancer. Ann Surg Oncol 2013, 20:4312-4321.
11. Nordlinger B., Sorbye H., Glimelius B., et al. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol 2013, 14:1208-1215.
12. Nordlinger B., Sorbye H., Glimelius B., et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 2008, 371:1007-1016.
13. Oh S.Y., Kim do Y., Kim Y.B., Suh K.W. Comparison of oncological outcomes between neoadjuvant and adjuvant chemotherapy combined with surgery for resectable synchronous colorectal liver metastases. J Surg Res 2013, 182:257-263.
14. Cucchetti A., Ercolani G., Cescon M., et al. Safety of hepatic resection for colorectal metastases in the era of neo-adjuvant chemotherapy. Langenbecks Arch Surg 2012, 397:397-405.
15. Pinto Marques H., Barroso E., de Jong M.C., et al. Peri-operative chemotherapy for resectable colorectal liver metastasis: does timing of systemic therapy matter?. J Surg Oncol 2012, 105:511-519.
16. Reddy S.K., Tsung A., Marsh J.W., Geller D.A. Does neoadjuvant chemotherapy reveal disease precluding surgical treatment of initially resectable colorectal cancer liver metastases?. J Surg Oncol 2012, 105:55-59.
17. Spelt L., Hermansson L., Tingstedt B., Andersson R. Influence of preoperative chemotherapy on the intraoperative and postoperative course of liver resection for colorectal cancer metastases. World J Surg 2012, 36:157-163.
18. Scartozzi M., Siquini W., Galizia E., et al. The timing of surgery for resectable metachronous liver metastases from colorectal cancer: better sooner than later? A retrospective analysis. Dig Liver Dis 2011, 43:194-198.
19. Boostrom S.Y., Nagorney D.M., Donohue J.H., et al. Impact of neoadjuvant chemotherapy with folfox/folfiri on disease-free and overall survival of patients with colorectal metastases. JGastrointest Surg 2009, 13:2003-2009.
20. Scoggins C.R., Campbell M.L., Landry C.S., Slomiany B.A., Woodall C.E., McMasters K.M., et al. Preoperative chemotherapy does not increase morbidity or mortality of hepatic resection for colorectal cancer metastases. Ann Surg Oncol 2009, 16:35-41.
21. Sahajpal A., Vollmer C.M., Dixon E., et al. Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri-operative outcomes. J Surg Oncol 2007, 95:22-27.
22. Pawlik T.M., Olino K., Gleisner A.L., Torbenson M., Schulick R., Choti M.A. Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome. J Gastrointest Surg 2007, 11:860-868.
23. Tanaka K., Adam R., Shimada H., Azoulay D., Lévi F., Bismuth H. Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. Br J Surg 2003, 90:963-969.
24. Allen P.J., Kemeny N., Jarnagin W., DeMatteo R., Blumgart L., Fong Y. Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. J Gastrointest Surg 2003, 7:109-115.
25. Sugihara K., Uetake H. Therapeutic strategies for hepatic metastasis of colorectal cancer: overview. J Hepatobiliary Pancreat Sci 2012, 19:523-527.
26. Tzeng C.W., Aloia T.A. Colorectal livermetastases. J Gastrointest Surg 2013, 17:195-201.
27. De Rosa A., Gomez D., Brooks A., Cameron I.C. "Liver-first" approach for synchronous colorectal liver metastases: is this a justifiable approach?. J Hepatobiliary Pancreat Sci 2013, 20:263-270.
28. Yin Z., Liu C., Chen Y., et al. Timing of hepatectomy in resectable synchronous colorectal liver metastases (SCRLM): simultaneous or delayed?. Hepatology 2013, 57:2346-2357.
29. Robinson S.M., Wilson C.H., Burt A.D., Manas D.M., White S.A. Chemotherapy-associated liver injury in patients with colorectal liver metastases: a systematic review and meta-analysis. Ann Surg Oncol 2012, 19:4287-4299.
30. JegatheeswaranSason J.M., Hancock H.C., Siriwardena A.K. The liver-first approach to the management of colorectal cancer with synchronous hepatic metastases: a systematic review. JAMA Surg 2013, 148:385-391.
31. Brouquet A., Nordlinger B. Surgical strategies to synchronous colorectal liver metastases. Dig Dis 2012, 30(Suppl. 2):132-136.